On June 6, 2023, the U.S. Food and Drug Administration (“FDA”) released draft guidance (“Draft Guidance”) updating Good Clinical Practices (“GCPs”) recommendations for interventional clinical trials involving human subjects. The Draft Guidance, which is aimed at enabling the incorporation of rapidly evolving technological and methodological innovations into clinical trials, is adapted from the International... READ MORE
U.S. Food and Drug Administration Issues Draft Guidance Updating Good Clinical Practices
Posted on June 29, 2023 in Health Law News
Published by: Hall Render
